Quick access for pharmaceutical companies: Here you will find general information on marketing authorisations and their follow-up procedures in a nutshell.

The BVL strives to simplify the national and European marketing authorisation procedures for veterinary medicinal products as well as the post-marketing procedures.

The application form including required annexes as well as information on how to apply for the approval of clinical trials according to §10 of the Veterinary Medicinal Products Act (TAMG) can be found here.

A supply shortage is an interruption of a delivery of veterinary medicinal products that is expected to last longer than 2 weeks or a significantly increased demand that cannot be met adequately.

More flexible interpretation of the legal framework for companies to respond to difficulties that may arise in the context of the pandemic.

The United Kingdom (UK) formally left the European Union (EU) on 31 January 2020 and became a third country. After ist withdrawal, UK no longer participates in the institutions and the decision-making of the EU – having regard to specific exemptions …

The forms required for submitting various procedural applications are available for download here.

The fees for official acts of the BVL are determined on the basis of fee ordiances.

Pharmacovigilance obligations and information for marketing authorisation, exemption and registration holders as well as co-distributors.

Here you will find links to other organisations providing further information.